ISTH 2022 Congress
Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies » VWF and von Willebrand Factor Disorders - Clinical Conditions
Theme Navigation
- ISTH 2022 Congress
- Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies
- VWF and von Willebrand Factor Disorders - Clinical Conditions
- Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies
-
Abstract Number: VPB0841
A case of hematidrosis complicated with von Willebrand disease
-
Abstract Number: PB0810
A novel role for subtle enhanced VWF clearance in Low VWF pathogenesis highlights limitations of VWFpp/VWF:Ag ratio assessment of clearance.
-
Abstract Number: PB0822
A quantitative evaluation of high-molecular forms of von Willebrand factor multimers in children’s with different types of vWD.
-
Abstract Number: PB0806
A screening assay for type 2B von Willebrand factor variants using an ELISA assay with ristocetin and a recombinant wild-type glycoprotein Ib.
-
Abstract Number: PB0826
A Systematic Review of Acquired von Willebrand Syndrome Associated With Cardiac Disorders: Epidemiology, Disease Burden, and Management
-
Abstract Number: PB0827
A Systematic Review of Acquired von Willebrand Syndrome Associated With Non-Cardiac Diseases: Epidemiology, Disease Burden, and Management
-
Abstract Number: PB0825
Burden of Illness in Patients With von Willebrand Disease Receiving Prophylaxis Versus Potential Prophylaxis-Eligible Patients: A Post-Hoc Analysis of A European Socioeconomic Study
-
Abstract Number: PB0824
Characteristics and Clinical Burden Among Patients With von Willebrand Disease Eligible for Prophylaxis: Results From a Retrospective US Cohort Study
-
Abstract Number: VPB0837
Characterization of Cellular Pathogenic Mechanism of Type 1 von Willebrand Disease with A1500V mutation
-
Abstract Number: OC 43.3
Clinical and phenotypic presentation of patients with low VWF in the Milan Center
-
Abstract Number: VPB0840
Correlation study between VWF: RCO ristocetin cofactor activity and ISTH-BAT in von Willebrand disease
-
Abstract Number: PB0821
Data mining for profiling the mutational landscape of von Willebrand disease
-
Abstract Number: PB0805
Development of Personalized CRISPR/Cas9 Based Gene Correction Therapy for Von Willebrand Disease
-
Abstract Number: VPB0839
Diagnostic Errors Of Von Willebrand Disease In A Developing Country: Analysis Of 38 Years Data
-
Abstract Number: OC 22.3
Effects of platelet-inspired haemostatic nanoparticles on bleeding in von Willebrand disease murine models
-
Abstract Number: PB0817
Emicizumab ameliorates hemostasis in von Willebrand Disease type 3 but not type 2A murine models
-
Abstract Number: PB0815
Evaluation of the diagnostic accuracy of VWF:Ac and VWF Ristocetin Cofactor Activity in the diagnosis of von Willebrand disease
-
Abstract Number: PB0828
Evaluation of within-subject variation of VWF multimers assay
-
Abstract Number: PB0832
Frequency of VWF single nucleotide variants in a single institution of Argentina.
-
Abstract Number: VPB0835
Hemoglobin concentration is a determinate of plasma VWF and FVIII levels